Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice. | Academic Article |
Why?
|
| Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy. | Academic Article |
Why?
|
| Distinct amyloid-ß and tau-associated microglia profiles in Alzheimer''s disease. | Academic Article |
Why?
|
| TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. | Academic Article |
Why?
|
| Rab11, but not Rab4, facilitates cyclic AMP- and tauroursodeoxycholate-induced MRP2 translocation to the plasma membrane. | Academic Article |
Why?
|
| Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer''s disease neuropathology and regional tau at autopsy. | Academic Article |
Why?
|
| Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition. | Academic Article |
Why?
|
| Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice. | Academic Article |
Why?
|
| Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease. | Academic Article |
Why?
|
| Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. | Academic Article |
Why?
|
| Human iPSC application in Alzheimer''s disease and Tau-related neurodegenerative diseases. | Academic Article |
Why?
|
| Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. | Academic Article |
Why?
|
| Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | Academic Article |
Why?
|
| Tau Secretion. | Academic Article |
Why?
|
| RNA binding proteins co-localize with small tau inclusions in tauopathy. | Academic Article |
Why?
|